Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
This study uses data from the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial to examine the incremental cost-effectiveness ratios of aflibercept, bevacizumab, and ranibizumab for the treatment of diabetic macular edema.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research
More News: Avastin | Diabetes | Endocrinology | Lucentis | Opthalmology | Ranibizumab Injection | Study